"The U.S. Food and Drug Administration today notified Ranbaxy Laboratories, Ltd., that it is prohibited from manufacturing and distributing active pharmaceutical ingredients (APIs) from its facility in Toansa, India, for FDA-regulated drug product"...
(Generic versions may still be available.)
oxytetracycline INTRAMUSCULAR SOLUTION*
FOR INTRAMUSCULAR USE ONLY contains 2% lidocaine
To reduce the development of drug-resistant bacteria and maintain the effectiveness of Terramycin (oxytetracycline) IM® and other antibacterial drugs, Terramycin (oxytetracycline) IM should be used only to treat or prevent infections that are proven or strongly suspected to be caused by bacteria.
Oxytetracycline diffuses readily through the placenta into the fetal circulation, into the pleural fluid and, under some circumstances, into the cerebrospinal fluid. It appears to be concentrated in the hepatic system and excreted in the bile, so that it appears in the feces, as well as in the urine, in a biologically active form.
|Terramycin Intramuscular contents per ml (m/v)|
|Ingredient||2 ml Single Dose
|10 ml Vial |
|100 mg/2 ml||250 mg/2 ml||50 mg/ml |
10 ml (5 β† 2 ml Doses)
|oxytetracycline||50 mg||125 mg||50 mg|
|magnesium chloride hexahydrate||2.5%||6.0%||2.5%|
|sodium formaldehyde sulfoxylate||0.5%||0.5%||0.3%|
|monoethanolamine||approx. 1.7%||approx. 4.2%||approx. 2.6%|
Last reviewed on RxList: 12/8/2004
This monograph has been modified to include the generic and brand name in many instances.
Additional Terramycin Information
Report Problems to the Food and Drug Administration
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.
Find out what women really need.